Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10316025
Substituted piperazine compounds and methods of use and use thereof
granted -
US 10314950
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 10314924
RPGR gene therapy for retinitis pigmentosa
granted -
US 10314908
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 10314900
Lutzomyia longipalpis polypeptides and methods of use
granted -
US 10314892
Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10314889
Suppression of allergic lung inflammation and hyperreactivity
granted -
US 10314840
2,4-pyrimidinediamine compounds and their uses
granted -
US 10314885
Oxytocin treatment to modify blood glucose and treat metabolic disease
granted -
CA 3079530
COMPOSITION LIQUIDE STABLE DE KETOPROFENE, SELS ET ENANTIOMERES DE CELUI-CI
granted -
US 10308591
Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
granted -
US 10307388
Compositions and methods for diagnosis and treatment of inflammation
granted -
US 10307407
9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors
granted -
US 10307418
Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
granted -
US 10307423
FBXO3 inhibitors
granted -
US 10307469
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
granted -
US 10308605
Proton pump inhibitors
granted -
US 10308646
Pyrimidine compound as JAK kinase inhibitor
granted -
US 10307481
CD37 immunotherapeutics and uses thereof
granted -
US 10308927
Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease
granted -
US 10308687
Cell-penetrating compstatin analogs and uses thereof
granted -
US 10308961
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10308941
Compositions and methods for inhibiting gene expression of factor XII
granted -
US 10308934
Compositions for modulating Ataxin 2 expression
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.